Rather & Kittrell’s Chemours CC Stock Holding History

Rather & Kittrell’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-135	Closed	-$4K	–	94
2021 Q4	$4K	Buy	+135	New	+$4.21K	﹤0.01%	263

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Rather & Kittrell's CC Position: Q1 2022 in Review

Rather & Kittrell sold out of Chemours (CC) in Q1 2022, closing a stake of 135 shares — an estimated $4K sold.

Rather & Kittrell first reported a position in CC in Q4 2021 and held it in 1 quarter. The position peaked at $4K in Q4 2021. 481 funds tracked by Wall St. Rank hold CC as of Q1 2022.

Rather & Kittrell reported no remaining Chemours position as of Q1 2022 after selling out during the quarter.
Rather & Kittrell sold 135 Chemours shares in Q1 2022, an estimated $4K.
Rather & Kittrell first reported a position in Chemours in Q4 2021 and held it in 1 quarter.
Rather & Kittrell's Chemours position peaked at $4K in Q4 2021.
481 funds tracked by Wall St. Rank held Chemours as of Q1 2022.

Based on Rather & Kittrell's 13F filing for Q1 2022, filed 10 May 2022.